文献速递胸部肿瘤

不可切除局部晚期NSCLC放疗:IASLC多学科实践解析

Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee.
PubMed 文献 · J Thorac Oncol · 2025-11-14

本文由IASLC多学科临床科学委员会与先进放疗技术小组撰写,围绕Ⅲ期NSCLC五个挑战性场景展开讨论,包括优化分期、靶向治疗在根治性放化疗中的角色、老年或合并症患者的治疗选择、新辅助系统治疗后未手术患者的管理,以及新辅助治疗后手术后的辅助放疗。文章以病例讨论形式综述多学科肿瘤委员会常见难题。

要点

  • Ⅲ期NSCLC异质性强,局部治疗选择需基于可切除性与可操作性判断。
  • 新辅助和辅助免疫治疗已改变Ⅲ期NSCLC的多学科管理模式。
  • 本文聚焦五个临床挑战场景,为多学科决策提供实践参考。

核心结论

  • 本文综述了胸部多学科肿瘤委员会中常遇到的五个挑战性临床场景,为Ⅲ期NSCLC的放疗决策提供多学科实践视角。

研究设计与样本

  • 由IASLC多学科临床科学委员会与先进放疗技术小组代表,以五个代表性病例讨论形式呈现挑战性场景。

主要发现

  • 第一个场景讨论根治性治疗前优化分期策略,尤其关注支气管内超声的作用。
  • 第二个场景聚焦靶向治疗在根治性放化疗范式中的角色。
  • 第三个场景评估老年或合并症患者的治疗选择,特别是放疗与系统治疗之间的取舍。
  • 第四个场景考虑新辅助系统治疗后未接受手术患者的管理。
  • 第五个场景关注新辅助治疗及手术后辅助放疗的作用。

临床怎么用

  • 本文以病例讨论形式梳理多学科肿瘤委员会常见难题,可供临床决策参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Stage III NSCLC is a heterogeneous disease with multiple curative and palliative treatment options. Surgery and radiotherapy are the primary local treatment modalities, and their use is guided by the principals of tumor resectability and patient operability. Neoadjuvant and adjuvant immunotherapies have changed the patterns of multidisciplinary management of stage III NSCLC. METHODS: On behalf of the Multidisciplinary Clinical Science Committee and Advanced Radiotherapy Technology Subcommittee of the International Association for the Study of Lung Cancer, we present five cases representing challenging scenarios for discussion. RESULTS: The first is strategies for optimizing staging before curative intent, particularly the role of endobronchial ultrasound. The second focuses on the role of targeted therapies in the curative-intent chemoradiotherapy paradigm. The third evaluates treatment approaches for elderly or comorbid patients, specifically the choice between radiotherapy and systemic therapy. The fourth considers the management of patients who do not undergo surgery after neoadjuvant systemic therapy. The fifth concerns the role of adjuvant radiotherapy after neoadjuvant therapy and surgery. CONCLUSIONS: Herein, we present a review of challenging clinical scenarios often encountered in thoracic multidisciplinary tumor boards.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Zhu H, Al Saifi S, Bahig H, et al. Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee. J Thorac Oncol. 2025. PMID: 41242499. doi:10.1016/j.jtho.2025.11.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。